Well Health - Digitale Services für die Medizin
eröffnet am 12.11.22 11:39:23 von
neuester Beitrag 21.05.24 15:48:53 von
neuester Beitrag 21.05.24 15:48:53 von
Beiträge: 109
ID: 1.364.777
ID: 1.364.777
Aufrufe heute: 2
Gesamt: 8.574
Gesamt: 8.574
Aktive User: 0
ISIN: CA94947L1022 · WKN: A2JQV6 · Symbol: W7V
2,4880
EUR
-0,20 %
-0,0050 EUR
Letzter Kurs 29.05.24 Tradegate
Neuigkeiten
TitelBeiträge |
---|
21.03.24 · IRW Press |
30.11.23 · IRW Press |
14.11.23 · IRW Press |
Werte aus der Branche Finanzdienstleistungen
Wertpapier | Kurs | Perf. % |
---|---|---|
0,9900 | +32,00 | |
1,6000 | +23,08 | |
1,05 | +7,14 | |
4,6467 | +7,07 | |
46,64 | +7,00 |
Wertpapier | Kurs | Perf. % |
---|---|---|
11,890 | -11,27 | |
1,1750 | -12,96 | |
6,5000 | -14,25 | |
2,6200 | -22,39 | |
0,5600 | -50,44 |
Beitrag zu dieser Diskussion schreiben
Das sind doch wieder mal gute Neuigkeiten und langsam haben die Kanadier wohl das Potenzial in well health Technologie gerade die immense Wertigkeit der 90% Beteiligung an der kleinen AI Tochter entdeckt. WO macht ja auch schön Werbung für die Kleine.
Well Health Stock Is Up 7% After Earnings: What Investors Need to Know
Well Health is benefiting from strong demand as it digitizes healthcare and strives to improve patient outcomes.
Technology companies like Well Health Technologies (TSX:WELL) are changing the world for the better. As a result, demand is high and expectations are high. Well Health Technologies reported its first-quarter earnings, which were a reflection of this — Well Health Technologies’s stock price is therefore up 7% since.
Here’s what you need to know. Well Health’s momentum remains strong
The first quarter was the 21st consecutive quarter of record-breaking results. Revenue increased 36.7% to $231 million, with organic growth of 13.5%, as patient visits soared 34% versus last year.
This was accompanied by a 6.1% increase in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to $28.3 million.
Finally, adjusted earnings per share (EPS) came in at $0.08 cents versus $0.06 cents last year and versus consensus expectations that were calling for EPS of negative $0.04.
Beyond this obvious strong momentum, the company signalled that it is now ready and able to focus more on shareholder returns. It’s what every investor wants to hear, and it comes right on time.
This means making good use of its growing free cash flow. In the quarter, free cash flow increased 11%, and for the year, management expects free cash flow to increase 30% to $50 million.
Also, management has made a commitment to reduce share-based compensation as well as increase share buybacks, effectively reducing or eliminating dilution in Well Health stock.
...
https://www.fool.ca/2024/05/17/well-health-stock-is-up-7-aft…
Well Health is benefiting from strong demand as it digitizes healthcare and strives to improve patient outcomes.
Technology companies like Well Health Technologies (TSX:WELL) are changing the world for the better. As a result, demand is high and expectations are high. Well Health Technologies reported its first-quarter earnings, which were a reflection of this — Well Health Technologies’s stock price is therefore up 7% since.
Here’s what you need to know. Well Health’s momentum remains strong
The first quarter was the 21st consecutive quarter of record-breaking results. Revenue increased 36.7% to $231 million, with organic growth of 13.5%, as patient visits soared 34% versus last year.
This was accompanied by a 6.1% increase in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to $28.3 million.
Finally, adjusted earnings per share (EPS) came in at $0.08 cents versus $0.06 cents last year and versus consensus expectations that were calling for EPS of negative $0.04.
Beyond this obvious strong momentum, the company signalled that it is now ready and able to focus more on shareholder returns. It’s what every investor wants to hear, and it comes right on time.
This means making good use of its growing free cash flow. In the quarter, free cash flow increased 11%, and for the year, management expects free cash flow to increase 30% to $50 million.
Also, management has made a commitment to reduce share-based compensation as well as increase share buybacks, effectively reducing or eliminating dilution in Well Health stock.
...
https://www.fool.ca/2024/05/17/well-health-stock-is-up-7-aft…
Antwort auf Beitrag Nr.: 75.752.751 von Chash-Carry am 08.05.24 15:40:16Gruß zurück und schönen Feiertag 🍻 siehst ja hier wie populär Well bisher ist ... wird schon 💰
Zitat von Chash-Carry: Was für ein Spaß, die Kanadier sind gerade aufgewacht und schwubs im Plus. Lass uns mal dabei bleiben. Hab dabei ein gutes Gefühl. Gruß an Winston 😉
Was für ein Spaß, die Kanadier sind gerade aufgewacht und schwubs im Plus. Lass uns mal dabei bleiben. Hab dabei ein gutes Gefühl. Gruß an Winston 😉
Bei uns wird kein Kurs gemacht. Darüber können wir froh sein. Die Kanadier kommen schon drauf, was hier möglich ist. Ich bleibe aufjedenfall erstmal dabei und mit einem Einstandskurs von knapp 2,5 sollte ich recht schnell wieder im Plus sein.
interessant sind auch die Kommentare des Vorstands
https://well.company/wp-content/uploads/2024/05/2024Q1MDA.pd…
https://well.company/wp-content/uploads/2024/05/2024Q1MDA.pd…
es läuft alles nach oben
ausser dem Kurs ... Well ist wohl bei vielen noch nicht auf dem Radar 😕Vancouver, BC - May 8, 2024
WELL achieved record quarterly revenues of $231.6 million in Q1-2024, an increase of 37% as compared to Q1-2023 driven by acquisitions and organic growth of 13% which includes growth related to our clinic absorption program.
WELL achieved Adjusted EBITDA¹ of $28.3 million in Q1-2024, an increase of 6% as compared to Q1-2023. WELL’s Canadian business grew its Adjusted EBITDA in Q1- 2024 by 19% to $14.6 million on a YoY basis.
WELL achieved Net Income of $19.6 million or $0.06 per share in Q1-2024 as compared to a loss of $10.6 million in Q1-2023 and Adjusted Net Income¹ of $20.2 million or $0.08 per share, 43% higher than Q1-2023.
WELL achieved free cashflow available to shareholders or “FCFA2S“ per share of $0.0511 a 11% increase over Q1-2023. WELL is pleased to provide guidance of an improvement of FCFA2S of more than $55M in 2024, a 30% increase from $42.4 million in 2023.
WELL increases its guidance range for 2024 annual revenue of between $960 million to $980 million, while guiding to upper range of its previous Adjusted EBITDA¹ guidance of $125 million to $130 million.
...
https://well.company/wp-content/uploads/2024/05/2024Q1FS.pdf
moin an Winston und andere wenn denn andere da sind 😀 morgen kommen die Zahlen für das erste Quartal. Dann ein webcall nur als Info. Also aufgepasst 😉
Antwort auf Beitrag Nr.: 75.727.167 von Chash-Carry am 03.05.24 17:13:15Entweder bezahlt von Well, denke aber eher die Betreiber von w:o haben sich selber mit ein paar Aktien eingedeckt
Zitat von Chash-Carry: Was mir auffällt ist das die Well Health Tech und die Tochtergesellschaft jetzt häufig hier als Schlagzeile laufen. Was steckt dahinter??? Hat einer eine Idee 💡? Das gute ist in Kanada werden viel mehr gehandelt als bei uns. 😀
Was mir auffällt ist das die Well Health Tech und die Tochtergesellschaft jetzt häufig hier als Schlagzeile laufen. Was steckt dahinter??? Hat einer eine Idee 💡? Das gute ist in Kanada werden viel mehr gehandelt als bei uns. 😀
21.03.24 · IRW Press · WELL Health Technologies |
30.11.23 · IRW Press · WELL Health Technologies |
14.11.23 · IRW Press · CAD/USD |